JAK-STAT3
Selected indexed studies
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer. (Nat Rev Clin Oncol, 2018) [PMID:29405201]
- JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target. (Front Pharmacol, 2024) [PMID:38495094]
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. (Cell Metab, 2018) [PMID:29249690]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Centella asiatica alleviates psoriasis through JAK/STAT3-mediated inflammation: An in vitro and in vivo study. (2023) pubmed
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer. (2018) pubmed
- JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target. (2024) pubmed
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. (2018) pubmed
- Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy. (2025) pubmed
- Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer's disease. (2025) pubmed
- Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK/STAT3 and JNK/c-Jun signaling. (2021) pubmed
- Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3β/PTEN/Akt pathway. (2023) pubmed
- The role of the JAK/STAT3 signaling pathway in acquired corneal diseases. (2024) pubmed
- The JAK/STAT3 axis: A comprehensive drug target for solid malignancies. (2017) pubmed